Faron Pharmaceuticals Oy (DI) (FARN) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Apr 2017 07:00 AM
RNS
Collaboration with Birmingham University
13 Apr 2017 01:43 PM
RNS
Purchase of Shares
04 Apr 2017 07:00 AM
RNS
Director/PDMR Shareholding
29 Mar 2017 07:00 AM
RNS
Final Results 2016
27 Mar 2017 09:23 AM
RNS
Holding(s) in Company
21 Mar 2017 11:05 AM
RNS
Second Price Monitoring Extn
21 Mar 2017 11:00 AM
RNS
Price Monitoring Extension
07 Mar 2017 10:54 AM
RNS
Holding(s) in Company
07 Mar 2017 07:00 AM
RNS
Notice of Full Year Results
03 Mar 2017 11:02 AM
RNS
Holding(s) in Company
01 Mar 2017 02:05 PM
RNS
Second Price Monitoring Extn
01 Mar 2017 02:00 PM
RNS
Price Monitoring Extension
01 Mar 2017 11:35 AM
RNS
Result of Placing & Subscription & Issue of Equity
28 Feb 2017 07:00 AM
RNS
Proposed Placing and Subscription
20 Feb 2017 07:00 AM
RNS
First Patient Recruited in Phase II RAAA Study
09 Feb 2017 07:00 AM
RNS
Faron update for 2017
09 Dec 2016 01:05 PM
RNS
Notification of Major Interest in Shares
09 Dec 2016 01:00 PM
RNS
Notification of Major Interest in Shares
05 Dec 2016 07:00 AM
RNS
PDMR Shareholding
21 Nov 2016 07:00 AM
RNS
Grant of options
31 Oct 2016 07:00 AM
RNS
New Application Accepted by Finnish Patent Office
24 Oct 2016 07:00 AM
RNS
First patient recruited in Japanese Ph III trial
07 Oct 2016 01:41 PM
RNS
Notification of Major Interest in Shares
06 Oct 2016 10:00 AM
RNS
Notification of Major Interest in Shares
05 Oct 2016 05:10 PM
RNS
Notification of Major Interest in Shares
26 Sep 2016 03:59 PM
RNS
Director Dealing
21 Sep 2016 11:27 AM
RNS
Raises £8.0 M through a Placing and Subscription
20 Sep 2016 07:00 AM
RNS
Proposed Placing & Subscription to raise £8M
05 Sep 2016 07:00 AM
RNS
Interim Results for six months ended 30 June 2016
10 Aug 2016 07:00 AM
RNS
Faron Pharmaceuticals Notice of Interim Results
25 Jul 2016 07:00 AM
RNS
Faron enters agreement with Abzena for Clevegen
22 Jun 2016 12:00 PM
RNS
Faron to Present at Proactive Investors Forum
14 Jun 2016 07:00 AM
RNS
Faron Provides Update at R&D Day
13 Jun 2016 07:00 AM
RNS
Faron Licenses Traumakine Rights to Pharmbio Korea
26 May 2016 10:53 AM
RNS
Faron Result of Annual General Meeting
26 May 2016 07:00 AM
RNS
Faron Expands R&D Strategy for Clevegen
13 May 2016 07:00 AM
RNS
Faron Pharmaceuticals Ltd to host an R&D Day
04 May 2016 07:00 AM
RNS
Notice of AGM
03 May 2016 07:00 AM
RNS
Faron Appoints New Medical Director
22 Apr 2016 07:00 AM
RNS
Faron Appoints Panmure Gordon as Joint Broker
19 Apr 2016 07:00 AM
RNS
Faron Files Two New Patents to Protect Clevegen
10 Mar 2016 07:00 AM
RNS
Annual Results for the year ended 31 December 2015
01 Mar 2016 07:00 AM
RNS
Faron files patent application for Traumakine
10 Feb 2016 07:00 AM
RNS
Notice of Preliminary Results
07 Jan 2016 07:00 AM
RNS
Top-line results from Japanese study of Traumakine
29 Dec 2015 07:00 AM
RNS
First Patient recruited in Phase III ARDS Study
21 Dec 2015 07:00 AM
RNS
Faron Awarded ?1.5 million Tekes Funding
30 Nov 2015 07:00 AM
RNS
Key Publication in Journal of Immunology
17 Nov 2015 07:30 AM
RNS
Admission to AIM and first day of dealings
UK 100

Latest directors dealings